EP 1366072 A2 20031203 - ETS-TRANSCRIPTION FACTOR RELATED COMPOUND SPECIFIC PROMOTER AND TRANSACTIVATORS THEREOF
Title (en)
ETS-TRANSCRIPTION FACTOR RELATED COMPOUND SPECIFIC PROMOTER AND TRANSACTIVATORS THEREOF
Title (de)
FÜR ETS-TRANSKRIPTIONSFAKTOR SPEZIFISCHER PROMOTER UND TRANSAKTIVATOREN DAVON
Title (fr)
PROMOTEUR SPECIFIQUE DE COMPOSE RELIE AU FACTEUR DE TRANSCRIPTION ETS, ET TRANSACTIVATEURS ASSOCIES
Publication
Application
Priority
- EP 01992719 A 20011031
- EP 0112662 W 20011031
- EP 00123842 A 20001102
Abstract (en)
[origin: WO0236620A2] The present invention relates to novel means for the treatment of diseases, in particular muscular diseases. The present invention relates to a nucleic acid capable of controlling the expression of a heterologous gene and of being selectively activated by an Ets-transcription factor related compound. The invention further relates to constructs, host cells comprising said nucleic acid, methods for recombinant expression of heterologous genes and methods for screening and identifying of candidate compounds having transcription regulatory activity using them. The invention additionally relates to a fusion protein for specifically activating said nucleic acid. The invention also relates to a kit comprising the nucleic acid and the fusion protein for recombinant expression of a heterologous gene.
IPC 1-7
IPC 8 full level
C07K 14/035 (2006.01); C07K 14/47 (2006.01); C12N 15/79 (2006.01)
CPC (source: EP)
C07K 14/005 (2013.01); C07K 14/47 (2013.01); C07K 14/4708 (2013.01); C12N 15/79 (2013.01); C07K 2319/00 (2013.01); C12N 2710/16622 (2013.01)
Citation (search report)
See references of WO 0236620A2
Designated contracting state (EPC)
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR
DOCDB simple family (publication)
WO 0236620 A2 20020510; WO 0236620 A3 20030605; WO 0236620 A9 20020919; AU 1907002 A 20020515; EP 1366072 A2 20031203
DOCDB simple family (application)
EP 0112662 W 20011031; AU 1907002 A 20011031; EP 01992719 A 20011031